These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. European investigational antiepilepsy drug trials. Sussman NM Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090 [No Abstract] [Full Text] [Related]
4. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Browne TR Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105 [No Abstract] [Full Text] [Related]
5. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy. Haskins LS; Tomaszewski KJ; Crawford P Epilepsy Behav; 2005 Aug; 7(1):98-105. PubMed ID: 15961350 [TBL] [Abstract][Full Text] [Related]
6. Patient recruitment and compliance issues in clinical trials. Cramer JA Epilepsy Res Suppl; 1993; 10():211-22. PubMed ID: 8251099 [No Abstract] [Full Text] [Related]
7. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636 [TBL] [Abstract][Full Text] [Related]
8. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000 [TBL] [Abstract][Full Text] [Related]
9. What's the problem with generic antiepileptic drugs?: a call to action. Berg MJ Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211 [No Abstract] [Full Text] [Related]
10. Sources of variability in clinical trials of new drugs for epilepsy. Leppik IE Epilepsy Res Suppl; 1993; 10():157-66. PubMed ID: 8251091 [No Abstract] [Full Text] [Related]
11. Preparing for an FDA audit. Barnes D Epilepsy Res Suppl; 1993; 10():245-50. PubMed ID: 8251103 [No Abstract] [Full Text] [Related]
12. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Ngo SN; Stupans I; McKinnon RA Epilepsy Behav; 2013 Jan; 26(1):64-6. PubMed ID: 23220461 [TBL] [Abstract][Full Text] [Related]
13. Protocol design. Wilensky AJ Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086 [No Abstract] [Full Text] [Related]
14. External influences on protocol design. Spilker B Epilepsy Res Suppl; 1993; 10():115-24. PubMed ID: 8251087 [No Abstract] [Full Text] [Related]
15. Current approaches to the use of generic antiepileptic drugs. Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678 [TBL] [Abstract][Full Text] [Related]
16. Pharmacy and generic substitution of antiepileptic drugs: missing in action? Welty TE Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833 [TBL] [Abstract][Full Text] [Related]
17. Comment: Pharmacy and generic substitution of antiepileptic drugs: missing in action? Hatton RC Ann Pharmacother; 2007 Sep; 41(9):1550-1; author reply 1551-2. PubMed ID: 17652128 [No Abstract] [Full Text] [Related]
18. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners. Barrett MW J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627 [TBL] [Abstract][Full Text] [Related]
20. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]